SCHEMBL7198274

SCHEMBL7198274

CCOC(=O)[C@H](N)CCCN

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CPB2 Q96IY4 2/20 0.51
▸ CYP1A2 P05177 1/20 0.50
▸ GSR P00390 1/20 0.47
▸ NOD1 Q9Y239 3/20 0.43
▸ DPP7 Q9UHL4 4/20 0.42
▸ DPP8 Q6V1X1 2/20 0.42
▸ DPP9 Q86TI2 2/20 0.42
▸ DPP4 P27487 2/20 0.42
▸ GNAI3 P08754 1/20 0.41
▸ GNAO1 P09471 1/20 0.41
▸ GNAI1 P63096 1/20 0.41
▸ ALOX15 P16050 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ RRM1 P23921 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7198273 1.00 CPB2 (0.51) CPB2CYP1A2GSRNOD1DPP7
SCHEMBL7198271 1.00 CPB2 (0.51) CPB2CYP1A2GSRNOD1DPP7
Hydrochloric Acid SCHEMBL15732755 0.98 CPB2 (0.50) CPB2CYP1A2GSRNOD1DPP7
Fluoride SCHEMBL27575703 0.98 CPB2 (0.50) CPB2CYP1A2GSRNOD1DPP7
Hydrochloric Acid SCHEMBL27218422 0.98 CPB2 (0.50) CPB2CYP1A2GSRNOD1DPP7
Hydrochloric Acid SCHEMBL11191635 0.98 CPB2 (0.50) CPB2CYP1A2GSRNOD1DPP7
Hydrochloric Acid SCHEMBL11191636 0.98 CPB2 (0.50) CPB2CYP1A2GSRNOD1DPP7
Fluoromethane SCHEMBL27575635 0.96 CPB2 (0.49) CPB2CYP1A2GSRNOD1DPP7
SCHEMBL213480 0.94 CPB2 (0.59) CPB2CYP1A2GSRNOD1DPP7
SCHEMBL249147 0.94 CPB2 (0.59) CPB2CYP1A2GSRNOD1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115656161-A Phthalic dicarboxaldehyde disinfectant concentration detection indicator card and preparation method thereof 利康医药科技江苏有限公司 2023-01-31 — — CN claimed
CN-108524446-B Functional pharmaceutical composition 朱瑞国 2020-05-08 — — CN claimed
CN-108542882-B Application of functional pharmaceutical composition 陈勇 2020-04-17 — — CN claimed
US-10420796-B2 Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease SEIKAGAKU CORPORATION (JP) 2019-09-24 — — US claimed
WO-2019076178-A1 DEGRADATION TIME CONTROLLABLE AND BREAKING ELONGATION ADJUSTABLE MEDICAL DEGRADABLE POLYURETHANE 凯斯蒂南京医疗器械有限公司 2019-04-25 — — WO claimed
CN-105997867-B Preparation method of functional pharmaceutical composition 南京康舟医药科技有限公司 2019-03-05 — — CN claimed
CN-108542882-A The application of functional drug composition 苏州益可泰电子材料有限公司 2018-09-18 — — CN claimed
CN-108524446-A Functional drug composition 苏州益可泰电子材料有限公司 2018-09-14 — — CN claimed
CN-107778446-A Degradation time is controllable, the adjustable medical degradable polyurethane of elongation at break 圆容生物医药无锡有限公司 2018-03-09 — — CN claimed
CN-105860057-B Biodegradable polymer based on the hydrophilic polyaminoacid of hydrophobic function small molecule and its preparation method and application 苏州大学 2018-01-19 — — CN claimed
EP-3246037-A1 CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE Seikagaku Corporation (JP) 2017-11-22 — — EP claimed
CN-105997867-A Functional pharmaceutical composition and preparation method thereof 苏州益可泰电子材料有限公司 2016-10-12 — — CN claimed
CN-105879048-A Preparation method of functional biodegradable nano particle based on polyamino acid 苏州大学张家港工业技术研究院 2016-08-24 — — CN claimed
CN-105860057-A Hydrophobic functional micromolecule-hydrophilic polyamino acid based biodegradable polymer and preparation method and application thereof 苏州大学 2016-08-17 — — CN claimed
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-26 — — US disclosed
US-20240399776-A1 COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL SANKO CO., LTD. (JP) 2024-12-05 — — US disclosed
CN-118725543-A High-service-life elastic cement damping material and preparation method thereof 河北洛德铁路配件有限公司 2024-10-01 — — CN disclosed
US-4716242-A ANTITUMOR AGENTS ASTA-WERKE AKTIENGESELLSCHAFT CHEMISCHE FABRIK (DE) 1987-12-29 — — US disclosed
CN-87100769-A Have 2-[2-[N, two (2-chloroethyl) the phosphinylidyne diamino oxygen bases of N-] ethyl] novel heterocyclic compound of group — 1987-09-02 — — CN disclosed
US-4413141-A INHIBITOR OF ORNITHINE DECARBOXYLASE MERRELL TORAUDE ET COMPAGNIE (FR) 1983-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION IDH3A, CA7, C9 CPB2 2157/4885CYP1A2 297/4885GSR 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback